111 related articles for article (PubMed ID: 37154584)
21. Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study).
Frontini MG; Srinivasan SR; Xu JH; Tang R; Bond MG; Berenson G
Am J Cardiol; 2007 Jul; 100(1):64-8. PubMed ID: 17599442
[TBL] [Abstract][Full Text] [Related]
22. Black-white differences in plasma levels of apolipoproteins: the Evans County Heart Study.
Heiss G; Schonfeld G; Johnson JL; Heyden S; Hames CG; Tyroler HA
Am Heart J; 1984 Sep; 108(3 Pt 2):807-14. PubMed ID: 6433686
[TBL] [Abstract][Full Text] [Related]
23. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.
Mora S; Buring JE; Ridker PM; Cui Y
Ann Intern Med; 2011 Dec; 155(11):742-50. PubMed ID: 22147713
[TBL] [Abstract][Full Text] [Related]
24. Associations of lipoprotein cholesterols, apolipoproteins A-I and B, and triglycerides with carotid atherosclerosis and coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) Study.
Sharrett AR; Patsch W; Sorlie PD; Heiss G; Bond MG; Davis CE
Arterioscler Thromb; 1994 Jul; 14(7):1098-104. PubMed ID: 8018665
[TBL] [Abstract][Full Text] [Related]
25. Major lipids, apolipoproteins, and risk of vascular disease.
; Di Angelantonio E; Sarwar N; Perry P; Kaptoge S; Ray KK; Thompson A; Wood AM; Lewington S; Sattar N; Packard CJ; Collins R; Thompson SG; Danesh J
JAMA; 2009 Nov; 302(18):1993-2000. PubMed ID: 19903920
[TBL] [Abstract][Full Text] [Related]
26. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
27. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
[TBL] [Abstract][Full Text] [Related]
28. The conjoint trait of low high-density lipoprotein cholesterol and high triglycerides in adolescent black and white males.
Morrison JA; Barton BA; Biro FM; Sprecher DL
Metabolism; 1998 May; 47(5):514-21. PubMed ID: 9591740
[TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
30. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
[TBL] [Abstract][Full Text] [Related]
31. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
[TBL] [Abstract][Full Text] [Related]
32. Is PSA related to serum cholesterol and does the relationship differ between black and white men?
Zapata D; Howard LE; Allott EH; Hamilton RJ; Goldberg K; Freedland SJ
Prostate; 2015 Dec; 75(16):1877-85. PubMed ID: 26332663
[TBL] [Abstract][Full Text] [Related]
33. Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer.
Murtola TJ; Kasurinen TVJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Prostate Cancer Prostatic Dis; 2019 Mar; 22(1):66-76. PubMed ID: 30214034
[TBL] [Abstract][Full Text] [Related]
34. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
Blais JE; Huang X; Zhao JV
Drugs; 2023 Apr; 83(5):403-427. PubMed ID: 36941490
[TBL] [Abstract][Full Text] [Related]
35. Cholesterol fractions and apolipoproteins as risk factors for heart disease mortality in older men.
Clarke R; Emberson JR; Parish S; Palmer A; Shipley M; Linksted P; Sherliker P; Clark S; Armitage J; Fletcher A; Collins R
Arch Intern Med; 2007 Jul; 167(13):1373-8. PubMed ID: 17620530
[TBL] [Abstract][Full Text] [Related]
36. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
[TBL] [Abstract][Full Text] [Related]
37. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
38. On-treatment non-high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin).
Mora S; Glynn RJ; Boekholdt SM; Nordestgaard BG; Kastelein JJ; Ridker PM
J Am Coll Cardiol; 2012 Apr; 59(17):1521-8. PubMed ID: 22516441
[TBL] [Abstract][Full Text] [Related]
39. Associations Between Life-Course Lipid Trajectories and Subclinical Atherosclerosis in Midlife.
Yan Y; Li S; Liu Y; Guo Y; Fernandez C; Bazzano L; He J; Chen W
JAMA Netw Open; 2022 Oct; 5(10):e2234862. PubMed ID: 36197664
[TBL] [Abstract][Full Text] [Related]
40. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study.
Parish S; Offer A; Clarke R; Hopewell JC; Hill MR; Otvos JD; Armitage J; Collins R;
Circulation; 2012 May; 125(20):2469-78. PubMed ID: 22539783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
